Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2021-47838
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Markright 1.0 - Persistent Cross-Site Scripting
Source: NVD (National Vulnerability Database)
Vulnerability Description
Markright 1.0 contains a persistent cross-site scripting vulnerability that allows attackers to embed malicious payloads in markdown files. Attackers can upload specially crafted markdown files that execute arbitrary JavaScript when opened, potentially enabling remote code execution on the victim's system.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:N
Source: NVD (National Vulnerability Database)
Vulnerability Type
在Web页面生成时对输入的转义处理不恰当(跨站脚本)
Source: NVD (National Vulnerability Database)
Vulnerability Title
markright 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
markright是David个人开发者的一个Markdown编辑器。 markright 1.0版本存在安全漏洞,该漏洞源于允许在markdown文件中嵌入恶意有效载荷,可能导致远程代码执行。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
dvcrnMarkright 1.0 -
II. Public POCs for CVE-2021-47838
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2021-47838
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2021-47838

No comments yet


Leave a comment